CClinicalTrials.gg
CompletedNCT07270224Updated Dec 26, 2025

Motor Imagery, Hand Mental Rotation, and Performance in Female Volleyball Players

An observational study in Motor Imagery, Volleyball and Reaction Time, sponsored by Medipol University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Medipol University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
52
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

This comparative cross-sectional study investigates the relationship between motor imagery (MI) ability, hand mental rotation (HMR), and performance outcomes in female volleyball players. Volleyball is a high-speed, cognitively demanding sport requiring precise motor coordination, rapid decision-making, and explosive movements. MI-the mental simulation of movement-and HMR-the cognitive manipulation of hand orientation-are critical for motor planning and execution. The study has two primary objectives: (1) to compare MI ability and HMR performance between female volleyball players and sedentary controls, and (2) to evaluate associations between MI/HMR scores and reaction time as well as vertical jump performance among volleyball players. The investigators hypothesize that volleyball players will exhibit superior MI and HMR abilities compared to controls, and that higher MI and HMR scores will correlate with faster reaction times and greater vertical jump height. Findings from this study will elucidate the cognitive-motor mechanisms underlying athletic performance and may inform training strategies to enhance neuromotor efficiency in sport-specific contexts.

02

Conditions studied

  • Motor Imagery
  • Volleyball
  • Reaction Time
  • Vertical Jump Performance
03

In context

Lead sponsor

Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

The study population consists of licensed female volleyball players competing in regional leagues and healthy female adults with no history of professional sports participation.

Eligibility criteria

Inclusion Criteria: Volleyball Group

  • Female participants aged 18-25 years
  • Licensed professional volleyball players competing in national or regional leagues
  • Currently playing an official main or secondary position
  • Minimum of 5 years of professional volleyball experience
  • Actively competing in volleyball for at least 1 year
  • Training more than 10 hours per week
  • No injury in the past 6 months that prevented participation in training or matches
  • Ability and willingness to participate voluntarily
  • Provided written informed consent

Inclusion Criteria: Control Group

  • Female participants aged 18-25 years
  • No history of participation in professional or recreational overhead sports
  • No lower extremity injury within the past 6 months
  • Less than 1 hour per week of structured exercise within the past 6 months
  • No previous licensed sports participation
  • Provided written informed consent

Exclusion Criteria (Applied to Both Groups)

  • Neurological, orthopedic, or systemic diseases
  • History of lower extremity injury in the past 6 months
  • Any pain, pathology, or instability affecting the upper or lower extremities
  • Regular medication use
  • Visual or hearing impairments
  • Diagnosed cognitive or attention disorders
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
52 participants (actual)
Patient registry
No

Groups and cohorts

  • Female Volleyball Players

    Female athletes currently participating in competitive volleyball; no intervention applied.

  • Controls Group

    Female individuals not engaged in regular physical activity; no intervention applied.

06

What researchers measure

Primary outcomes

  1. Mental Chronometry Test

    Mental chronometry ratio calculated as \|Actual Time - Imagined Time\| / Actual Time, measured during five actual vertical jumps and five imagined vertical jumps. Lower values indicate better motor imagery performance. Time measured in seconds using a stopwatch; ratio is unitless.

    Time frame: Baseline (single assessment during the initial study visit)

Secondary outcomes

  1. Hand Mental Rotation Task

    Mean response time (milliseconds) for left/right hand discrimination tasks in the Orientate® application. Lower values indicate faster cognitive processing related to mental rotation.

    Time frame: Baseline

  2. Reaction Time (ms)

    Mean reaction time across three trials measured using the BlazePod® wireless LED sensor system. Participants respond to visual stimuli with their dominant hand. Lower values indicate better reaction performance.

    Time frame: Baseline

  3. Vertical Jump Height (cm)

    Mean jump height calculated from three countermovement jumps recorded and analyzed using the My Jump 2 smartphone application. Higher values indicate better lower-limb explosive performance.

    Time frame: Baseline

07

Study locations

2 sites
  • Istanbul Medipol University
    Istanbul, Beykoz 34158, Turkey (Türkiye)
  • Ayşe Yazgan
    Bakırköy, Istanbul 34158, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07270224
Lead sponsor
Medipol University
Responsible party
Ayse Yazgan (Principal Investigator, Medipol University) — Principal investigator
First posted
Dec 8, 2025
Start date
Nov 10, 2025
Primary completion
Nov 25, 2025
Completion
Dec 10, 2025
Last update
Dec 26, 2025

Study contacts

Ayşe Yazgan
principal investigator · Medipol University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion